Payment overview · 2025
General Payments
$263.97
4 reported records · 4 companies
Healthcare provider profile · identity verified
Randall Wooley, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · DALLAS, TX · NPI 1639154966
Verified facts
What the public records show
CMS Open Payments records show Randall Wooley, M.D. received $263.97 in general payments during 2025 across 4 reported records.
Aurinia Pharma U.S., Inc. accounted for 58.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Aurinia Pharma U.S., Inc. | Unresolved — no canonical attribution shown | $154.26 | 58.4% | 1 | 2025 |
| Cleerly, Inc. | Unresolved — no canonical attribution shown | $67.96 | 25.8% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $24.57 | 9.3% | 1 | 2025 |
| Echosens North America, Inc. | Unresolved — no canonical attribution shown | $17.18 | 6.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $263.97 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LUPKYNIS Normalized: lupkynis |
Drug | Aurinia Pharma U.S., Inc. | $154.26 | 1 | 2025 |
Source payment records
|
|||||
| Cleerly Ischemia Normalized: cleerly ischemia |
Device | Cleerly, Inc. | $67.96 | 1 | 2025 |
Source payment records
|
|||||
| Cleerly Labs Normalized: cleerly labs |
Device | Cleerly, Inc. | $67.96 | 1 | 2025 |
Source payment records
|
|||||
| PROCLAIM Normalized: proclaim |
Device | Abbott Laboratories | $24.57 | 1 | 2025 |
Source payment records
|
|||||
| Fibroscan Normalized: fibroscan |
Device | Echosens North America, Inc. | $17.18 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 747 | 200 |
| Losartan Potassium | Losartan Potassium | 536 | 128 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 491 | 135 |
| Atorvastatin Calcium | Atorvastatin Calcium | 481 | 135 |
| Levothyroxine Sodium | Levothyroxine Sodium | 465 | 118 |
| Simvastatin | Simvastatin | 266 | 72 |
| Lisinopril | Lisinopril | 237 | 66 |
| Pantoprazole Sodium | Pantoprazole Sodium | 223 | 59 |
| Hydrochlorothiazide | Hydrochlorothiazide | 209 | 59 |
| Montelukast Sodium | Montelukast Sodium | 207 | 58 |
| Pravastatin Sodium | Pravastatin Sodium | 207 | 67 |
| Metformin Hcl Er | Metformin Hcl | 196 | 58 |
| Metformin Hcl | Metformin Hcl | 194 | 45 |
| Gabapentin | Gabapentin | 190 | 35 |
| Zolpidem Tartrate | Zolpidem Tartrate | 174 | 42 |
| Trazodone Hcl | Trazodone Hcl | 171 | 34 |
| Omeprazole | Omeprazole | 163 | 38 |
| Sertraline Hcl | Sertraline Hcl | 163 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 161 | 36 |
| Carvedilol | Carvedilol | 153 | 40 |
| Metoprolol Succinate | Metoprolol Succinate | 147 | 36 |
| Potassium Chloride | Potassium Chloride | 142 | 39 |
| Valsartan | Valsartan | 142 | 37 |
| Alprazolam | Alprazolam | 138 | 30 |
| Ozempic | Semaglutide | 130 | 20 |
| Synthroid | Levothyroxine Sodium | 128 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 125 | 30 |
| Ezetimibe | Ezetimibe | 124 | 41 |
| Alendronate Sodium | Alendronate Sodium | 110 | 32 |
| Duloxetine Hcl | Duloxetine Hcl | 104 | 20 |
| Allopurinol | Allopurinol | 103 | 30 |
| Meloxicam | Meloxicam | 102 | 24 |
| Eliquis | Apixaban | 100 | 23 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 99 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 96 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 92 | 30 |
| Furosemide | Furosemide | 92 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 80 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 75 | 20 |
| Bupropion Xl | Bupropion Hcl | 68 | 16 |
| Clonazepam | Clonazepam | 67 | 16 |
| Valacyclovir | Valacyclovir Hcl | 67 | 23 |
| Finasteride | Finasteride | 60 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 59 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 58 | 16 |
| Lovastatin | Lovastatin | 57 | 17 |
| Lorazepam | Lorazepam | 54 | suppressed |
| Telmisartan | Telmisartan | 54 | 14 |
| Tramadol Hcl | Tramadol Hcl | 54 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 47 | 11 |
| Estradiol | Estradiol | 44 | 16 |
| Buspirone Hcl | Buspirone Hcl | 43 | 13 |
| Memantine Hcl | Memantine Hcl | 42 | suppressed |
| Atenolol | Atenolol | 41 | 12 |
| Candesartan Cilexetil | Candesartan Cilexetil | 41 | suppressed |
| Celecoxib | Celecoxib | 41 | 15 |
| Jardiance | Empagliflozin | 41 | suppressed |
| Mirtazapine | Mirtazapine | 41 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 40 | 17 |
| Donepezil Hcl | Donepezil Hcl | 38 | 11 |
| Irbesartan | Irbesartan | 38 | 13 |
| Xarelto | Rivaroxaban | 38 | suppressed |
| Ondansetron Odt | Ondansetron | 37 | suppressed |
| Glimepiride | Glimepiride | 36 | 11 |
| Torsemide | Torsemide | 36 | 13 |
| Trulicity | Dulaglutide | 36 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 35 | suppressed |
| Spironolactone | Spironolactone | 35 | suppressed |
| Belsomra | Suvorexant | 34 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 34 | 13 |
| Chlorthalidone | Chlorthalidone | 33 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 31 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 31 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 29 | 21 |
| Raloxifene Hcl | Raloxifene Hcl | 27 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Aripiprazole | Aripiprazole | 22 | suppressed |
| Januvia | Sitagliptin Phosphate | 22 | suppressed |
| Klor-Con M20 | Potassium Chloride | 22 | suppressed |
| Rivastigmine | Rivastigmine | 22 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Minoxidil | Minoxidil | 21 | suppressed |
| Myrbetriq | Mirabegron | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Linzess | Linaclotide | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 18 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 18 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 18 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 14 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 15 | suppressed |
| Famotidine | Famotidine | 15 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 15 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 15 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 14 | suppressed |
| Eszopiclone | Eszopiclone | 14 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 14 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 14 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 14 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 14 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 13 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 13 | suppressed |
| Invokana | Canagliflozin | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | 12 |
| Clonidine | Clonidine | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 11 | suppressed |
| Droxidopa | Droxidopa | 11 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 11 | suppressed |
| Galantamine Er | Galantamine Hbr | 11 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $263.97 · 4 records | Aurinia Pharma U.S., Inc. | Cleerly Ischemia, Cleerly Labs, Fibroscan, LUPKYNIS, PROCLAIM | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error